Journal articles on the topic 'Triple negative breast neoplasms/pathology'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Triple negative breast neoplasms/pathology.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Segovia-Mendoza, Mariana, Susana Romero-Garcia, Cristina Lemini, and Heriberto Prado-Garcia. "Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation." Journal of Immunology Research 2021 (January 7, 2021): 1–18. http://dx.doi.org/10.1155/2021/6668573.
Full textSegovia-Mendoza, Mariana, Susana Romero-Garcia, Cristina Lemini, and Heriberto Prado-Garcia. "Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation." Journal of Immunology Research 2021 (January 7, 2021): 1–18. http://dx.doi.org/10.1155/2021/6668573.
Full textGeyer, Felipe C., Samuel H. Berman, Caterina Marchiò, Kathleen A. Burke, Elena Guerini-Rocco, Salvatore Piscuoglio, Charlotte KY Ng, et al. "Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family." Modern Pathology 30, no. 1 (October 7, 2016): 69–84. http://dx.doi.org/10.1038/modpathol.2016.161.
Full textNadhan, Revathy, Jayashree Vijaya Vaman, Satheesh Kumar Sengodan, Sreelatha Krishnakumar Hemalatha, Nirmala Chellappan, Santha Sadasivan, Aysha Pasuthottiyil Varkey, et al. "BRCA1 promoter hypermethylation in human placenta: a hidden link with β-hCG expression." Carcinogenesis 41, no. 5 (June 14, 2019): 611–24. http://dx.doi.org/10.1093/carcin/bgz117.
Full textLivasy, Chad A. "Triple-Negative Breast Carcinoma." Surgical Pathology Clinics 2, no. 2 (June 2009): 247–61. http://dx.doi.org/10.1016/j.path.2009.02.005.
Full textBose, Shikha. "Triple-negative Breast Carcinoma." Advances In Anatomic Pathology 22, no. 5 (September 2015): 306–13. http://dx.doi.org/10.1097/pap.0000000000000084.
Full textLerma, Enrique, Agusti Barnadas, and Jaime Prat. "Triple Negative Breast Carcinomas." Applied Immunohistochemistry & Molecular Morphology 17, no. 6 (December 2009): 483–94. http://dx.doi.org/10.1097/pai.0b013e3181a725eb.
Full textDietze, Eric C., Tanya A. Chavez, and Victoria L. Seewaldt. "Obesity and Triple-Negative Breast Cancer." American Journal of Pathology 188, no. 2 (February 2018): 280–90. http://dx.doi.org/10.1016/j.ajpath.2017.09.018.
Full textShousha, Sami, David Peston, Ondrej Gojis, and Carlo Palmieri. "An unusual triple-negative breast carcinoma." Histopathology 55, no. 3 (September 2009): 364–66. http://dx.doi.org/10.1111/j.1365-2559.2009.03349.x.
Full textGeyer, Felipe C., Fresia Pareja, Britta Weigelt, Emad Rakha, Ian O. Ellis, Stuart J. Schnitt, and Jorge S. Reis-Filho. "The Spectrum of Triple-Negative Breast Disease." American Journal of Pathology 187, no. 10 (October 2017): 2139–51. http://dx.doi.org/10.1016/j.ajpath.2017.03.016.
Full textO'Toole, Sandra A., Jane M. Beith, Ewan K. A. Millar, Richard West, Anna McLean, Aurelie Cazet, Alexander Swarbrick, and Samantha R. Oakes. "Therapeutic targets in triple negative breast cancer." Journal of Clinical Pathology 66, no. 6 (February 22, 2013): 530–42. http://dx.doi.org/10.1136/jclinpath-2012-201361.
Full textKhan, Ashraf, and Otto Walter. "IMP3 expression in triple-negative breast carcinoma - Reply." Human Pathology 41, no. 9 (September 2010): 1356–57. http://dx.doi.org/10.1016/j.humpath.2010.05.005.
Full textMiller, Tiffany Renee, Ashlie Elizabeth Rubrecht, Jaya Ruth Asirvatham, Mehmet R. Genc, and Archana Shenoy. "Microscopic Placental Metastasis in Triple Negative Breast Carcinoma." International Journal of Surgical Pathology 28, no. 5 (October 15, 2019): 521–22. http://dx.doi.org/10.1177/1066896919880964.
Full textRao, Deepthi, Bruce F. Kimler, Warren B. Nothnick, Marilyn K. Davis, Fang Fan, and Ossama Tawfik. "Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non–triple-negative breast cancers." Human Pathology 46, no. 6 (June 2015): 876–83. http://dx.doi.org/10.1016/j.humpath.2015.02.015.
Full textJiagge, Evelyn, Dhananjay Chitale, and Lisa A. Newman. "Triple-Negative Breast Cancer, Stem Cells, and African Ancestry." American Journal of Pathology 188, no. 2 (February 2018): 271–79. http://dx.doi.org/10.1016/j.ajpath.2017.06.020.
Full textJung, Hee Chan, Sung Hwan Kim, Jeong Hoon Lee, Ju Han Kim, and Sung Won Han. "Gene Regulatory Network Analysis for Triple-Negative Breast Neoplasms by Using Gene Expression Data." Journal of Breast Cancer 20, no. 3 (2017): 240. http://dx.doi.org/10.4048/jbc.2017.20.3.240.
Full textRomero, Pierre, Vanessa Benhamo, Gabrielle Deniziaut, Laetitia Fuhrmann, Frédérique Berger, Elodie Manié, Jaydutt Bhalshankar, et al. "Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression." American Journal of Pathology 188, no. 10 (October 2018): 2378–91. http://dx.doi.org/10.1016/j.ajpath.2018.06.021.
Full textMatikas, Alexios, Georgios Lazaridis, and Sofa Agelaki. "Triple-Negative Breast Cancer: One Or More Entities?" Forum of Clinical Oncology 5, no. 2 (December 10, 2014): 20–31. http://dx.doi.org/10.2478/fco-2014-0010.
Full textD'Alfonso, Timothy M., Jeffrey Hannah, Zhengming Chen, Yifang Liu, Pengbo Zhou, and Sandra J. Shin. "Axl receptor tyrosine kinase expression in breast cancer." Journal of Clinical Pathology 67, no. 8 (June 5, 2014): 690–96. http://dx.doi.org/10.1136/jclinpath-2013-202161.
Full textDowns-Kelly, Erinn, and Michael Z. Gilcrease. "Matrix-producing Carcinoma: Just Another Triple-negative Breast Cancer?" American Journal of Surgical Pathology 34, no. 1 (January 2010): 125–26. http://dx.doi.org/10.1097/pas.0b013e3181c4badf.
Full textDusenbery, Anna C., Joseph L. Maniaci, Natalie D. Hillerson, Erik A. Dill, Timothy N. Bullock, and Anne M. Mills. "MHC Class I Loss in Triple-negative Breast Cancer." American Journal of Surgical Pathology 45, no. 5 (January 11, 2021): 701–7. http://dx.doi.org/10.1097/pas.0000000000001653.
Full textThike, Aye Aye, Poh Yian Cheok, Ana Richelia Jara-Lazaro, Benita Tan, Patrick Tan, and Puay Hoon Tan. "Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer." Modern Pathology 23, no. 1 (October 23, 2009): 123–33. http://dx.doi.org/10.1038/modpathol.2009.145.
Full textHanna, Courtney A., Isam Eltoum, and Shantel Hebert-Magee. "Triple Negative Breast Cancer: Are There Rapidly Distinguishable Cytomorphological Features?" Journal of the American Society of Cytopathology 2, no. 1 (October 2013): S7—S8. http://dx.doi.org/10.1016/j.jasc.2013.08.017.
Full textZhou, Ling, Ke Li, Yanli Luo, Ling Tian, Min Wang, Chuanyuan Li, and Qian Huang. "Novel prognostic markers for patients with triple-negative breast cancer." Human Pathology 44, no. 10 (October 2013): 2180–87. http://dx.doi.org/10.1016/j.humpath.2013.03.021.
Full textGuney Eskiler, Gamze, Gulsah Cecener, Unal Egeli, and Berrin Tunca. "Triple negative breast cancer: new therapeutic approaches andBRCAstatus." APMIS 126, no. 5 (April 25, 2018): 371–79. http://dx.doi.org/10.1111/apm.12836.
Full textAmeer, Amna, Farhan Akhtar, Hafeez Ud Din, and Rabia Ahmad. "IMMUNOHISTOCHEMICAL EXPRESSION OF ANDROGEN RECEPTOR IN TRIPLE NEGATIVE BREAST CARCINOMA AT ARMED FORCES INSTITUTE OF PATHOLOGY, RAWALPINDI." PAFMJ 71, no. 1 (February 23, 2021): 7–11. http://dx.doi.org/10.51253/pafmj.v71i1.4687.
Full textTolba, NS, AS Alsedfy, SW Skandar, and YM El-Kerm. "Expression of Transgelin in Triple Negative and Non Triple Negative Breast Cancer: A Differential Study." Tumori Journal 106, no. 1_suppl (April 2020): 20. http://dx.doi.org/10.1177/0300891620914150.
Full textKala, Chayanika, Mohd Athar, Sanjay Kala, Lubna Khan, RamendraK Jauhari, and Amitabh Satsangi. "Clinical and cyto-morphological characterization of triple negative breast cancer." Journal of Cytology 36, no. 2 (2019): 84. http://dx.doi.org/10.4103/joc.joc_47_18.
Full textVona-Davis, Linda, David P. Rose, Vijaya Gadiyaram, Barbara Ducatman, Gerald Hobbs, Hannah Hazard, Sobha Kurian, and Jame Abraham. "Breast Cancer Pathology, Receptor Status, and Patterns of Metastasis in a Rural Appalachian Population." Journal of Cancer Epidemiology 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/170634.
Full textLiu, Huan-Tao, Rong Ma, Qi-Feng Yang, Gang Du, and Cui-Juan Zhang. "Lymphangiogenic Characteristics of Triple Negativity in Node-Negative Breast Cancer." International Journal of Surgical Pathology 17, no. 6 (June 3, 2009): 426–31. http://dx.doi.org/10.1177/1066896909337505.
Full textYu, Kangjie, Joseph Rohr, Yang Liu, Mingyang Li, Junpeng Xu, Kaijing Wang, Jia Chai, et al. "Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets." Pathology - Research and Practice 216, no. 4 (April 2020): 152874. http://dx.doi.org/10.1016/j.prp.2020.152874.
Full textAlsaleem, Mansour A., Graham Ball, Michael S. Toss, Sara Raafat, Mohammed Aleskandarany, Chitra Joseph, Angela Ogden, et al. "A novel prognostic two-gene signature for triple negative breast cancer." Modern Pathology 33, no. 11 (May 13, 2020): 2208–20. http://dx.doi.org/10.1038/s41379-020-0563-7.
Full textGinter, Paula S., Zhiyan Fu, and Sandra J. Shin. "Low-grade variants of triple-negative breast carcinoma (TNBC): a review." Diagnostic Histopathology 26, no. 2 (February 2020): 51–60. http://dx.doi.org/10.1016/j.mpdhp.2019.10.019.
Full textUeda, Ai, Keiki Oikawa, Koji Fujita, Akio Ishikawa, Eiichi Sato, Takashi Ishikawa, Masahiko Kuroda, and Kohsuke Kanekura. "Therapeutic potential of PLK1 inhibition in triple-negative breast cancer." Laboratory Investigation 99, no. 9 (April 17, 2019): 1275–86. http://dx.doi.org/10.1038/s41374-019-0247-4.
Full textSullivan, Harold C., Gabriela Oprea-Ilies, Amy L. Adams, Andrew J. Page, Sungjin Kim, Jason Wang, and Cynthia Cohen. "Triple-negative Breast Carcinoma in African American and Caucasian Women." Applied Immunohistochemistry & Molecular Morphology 22, no. 1 (January 2014): 17–23. http://dx.doi.org/10.1097/pai.0b013e318281148e.
Full textMrklić, Ivana, Zenon Pogorelić, Vesna Ćapkun, and Snježana Tomić. "Expression of Topoisomerase II-α in Triple Negative Breast Cancer." Applied Immunohistochemistry & Molecular Morphology 22, no. 3 (March 2014): 182–87. http://dx.doi.org/10.1097/pai.0b013e3182910967.
Full textO’Reilly, Elma A., Luke Gubbins, Shiva Sharma, Riona Tully, Matthew Ho Zhing Guang, Karolina Weiner-Gorzel, John McCaffrey, et al. "The fate of chemoresistance in triple negative breast cancer (TNBC)." BBA Clinical 3 (June 2015): 257–75. http://dx.doi.org/10.1016/j.bbacli.2015.03.003.
Full textParry, S., K. Savage, C. Marchiò, and J. S. Reis-Filho. "Nestin is expressed in basal-like and triple negative breast cancers." Journal of Clinical Pathology 61, no. 9 (July 19, 2008): 1045–50. http://dx.doi.org/10.1136/jcp.2008.058750.
Full textSahin Ozkan, Hulya, Mustafa Umit Ugurlu, Perran Fulden Yumuk, and Handan Kaya. "Prognostic Role of Immune Markers in Triple Negative Breast Carcinoma." Pathology & Oncology Research 26, no. 4 (July 17, 2020): 2733–45. http://dx.doi.org/10.1007/s12253-020-00874-4.
Full textMatsumoto, Hirofumi, Si-lin Koo, Rebecca Dent, Puay Hoon Tan, and Jabed Iqbal. "Role of inflammatory infiltrates in triple negative breast cancer: Table 1." Journal of Clinical Pathology 68, no. 7 (March 6, 2015): 506–10. http://dx.doi.org/10.1136/jclinpath-2015-202944.
Full textLiu, Rong-Zong, Kathryn Graham, Darryl D. Glubrecht, Devon R. Germain, John R. Mackey, and Roseline Godbout. "Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer." American Journal of Pathology 178, no. 3 (March 2011): 997–1008. http://dx.doi.org/10.1016/j.ajpath.2010.11.075.
Full textKrings, Gregor, Michael Nystrom, Irum Mehdi, Poonam Vohra, and Yunn-Yi Chen. "Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer." Human Pathology 45, no. 11 (November 2014): 2225–32. http://dx.doi.org/10.1016/j.humpath.2014.06.022.
Full textVtorushin, S. V., N. V. Krakhmal, and M. V. Zavyalova. "Triple-negative breast cancer. Modern molecular genetic concepts and their clinical significance." Arkhiv patologii 83, no. 3 (2021): 46. http://dx.doi.org/10.17116/patol20218302146.
Full textLoo, Claudette E., Marieke E. Straver, Sjoerd Rodenhuis, Sara H. Muller, Jelle Wesseling, Marie-Jeanne T. F. D. Vrancken Peeters, and Kenneth G. A. Gilhuijs. "Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype." Journal of Clinical Oncology 29, no. 6 (February 20, 2011): 660–66. http://dx.doi.org/10.1200/jco.2010.31.1258.
Full textKuroda, Naoto, Masahiko Ohara, Kaori Inoue, Keiko Mizuno, Nokiaki Fujishima, Nobumasa Hamaguchi, and Gang-Hong Lee. "The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma." Medical Molecular Morphology 42, no. 2 (June 2009): 128–31. http://dx.doi.org/10.1007/s00795-008-0428-5.
Full textKim, Ji Yeon, Taeeun Kim, and Eun Yoon Cho. "Comparative Study of Metaplastic Breast Carcinoma and Triple-Negative Breast Carcinoma Using Histologic and Immunohistochemical Analyses." Korean Journal of Pathology 44, no. 6 (2010): 605. http://dx.doi.org/10.4132/koreanjpathol.2010.44.6.605.
Full textRoitberg, G. E., J. V. Dorosh, and O. Yu Anikeeva. "Treatment of thrice-negative breast cancer in a patient with metabolic syndrome." Research and Practical Medicine Journal 8, no. 1 (March 10, 2021): 62–68. http://dx.doi.org/10.17709/2409-2231-2021-8-1-6.
Full textHashmi, Atif, Muhammad Edhi, Hanna Naqvi, Naveen Faridi, Amna Khurshid, and Mehmood Khan. "Clinicopathologic features of triple negative breast cancers: an experience from Pakistan." Diagnostic Pathology 9, no. 1 (2014): 43. http://dx.doi.org/10.1186/1746-1596-9-43.
Full textLi, Mingyang, Jingwei Liu, Sihui Li, Yanling Feng, Fei Yi, Liang Wang, Shi Wei, and Liu Cao. "Autophagy-related 7 modulates tumor progression in triple-negative breast cancer." Laboratory Investigation 99, no. 9 (April 15, 2019): 1266–74. http://dx.doi.org/10.1038/s41374-019-0249-2.
Full textAtchley, Deann P., Constance T. Albarracin, Adriana Lopez, Vicente Valero, Christopher I. Amos, Ana Maria Gonzalez-Angulo, Gabriel N. Hortobagyi, and Banu K. Arun. "Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer." Journal of Clinical Oncology 26, no. 26 (September 10, 2008): 4282–88. http://dx.doi.org/10.1200/jco.2008.16.6231.
Full text